The International Journal of Frontier Sciences

(ISSN: 2618-0367) Open Access Journal
Rss Feed:
Int J Front Sci 2024, 4(2), 1; doi: 10.37978/tijfs.v4i2.291

Mortality Analysis of COVID-19 Confirmed Cases in Pakistan

Received: 14 Jan 2026 / Published: 25 Jul 2024
Download PDF (270kb)

Abstract

Introduction: COVID-19, a novel disease, appeared in December 2019 in China and rapidly spread across the world. Till the second week of April 2020, high incidence (2.9/100,000) and cases fatality rates (1.7%) were observed in Pakistan. This study was conducted to determine the temporal and spatial distribution of the first 100 deaths attributed to COVID-19 in Pakistan and their associated demographic factors. Method: A record review of the first 100 deaths reported among RT-PCR confirmed COVID-19 cases was conducted. Demographic, epidemiological, and risk factors information was obtained associated comorbidities and clinical signs and symptoms were recorded and frequencies were determined. Results: A total of 100 mortalities with an overall case fatality rate of 1.67% (CFR) were analyzed. The median age of patients was 64.5 years (IQR: 54-70) with 75% (n=75) males. Among all deaths reported, 71 (71%) cases had one or more documented comorbidities at the time of diagnosis. The most frequently reported co-morbidities were: hypertension (67%), followed by Diabetes Mellitus (45%) and Ischemic Heart Diseases (27%). The most frequent presenting symptoms were shortness of breath (87%) and fever (79%). The median duration of illness was eight days (IQR: 4-11 days), the median delay reaching hospital to seek health care was three days (IQR: 0-6 days) while the median duration of hospital stay was also three days (IQR: 1-7 days). Among all, 62% had no history of international travel. The most affected age group was 60-69 years while no death reported in the age group below 20 years.
Keywords: Pakistan,Epidemiology,Co-morbidities,Cases Fatality Rate,Covid-19
OPEN ACCESS
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
CITE
Chaudhry, A.; Ikram, A.; Baig, M.A.; Salman, M.; Ghafoor, T.; Hussain, Z.; Khan, M.A.; Ansari, J.A.; Syed, A.; Javed, W.; Larik, E.; Mohsan, M.; Masood, N.; Iqbal, Z.; Akram, K. Mortality Analysis of COVID-19 Confirmed Cases in Pakistan. Int J Front Sci 2024, 4, 1.
Chaudhry A, Ikram A, Baig MA, Salman M, Ghafoor T, Hussain Z, Khan MA, Ansari JA, Syed A, Javed W, Larik E, Mohsan M, Masood N, Iqbal Z, Akram K. Mortality Analysis of COVID-19 Confirmed Cases in Pakistan. Int J Front Sci. 2024; 4(2):1.
Chaudhry, Ambreen; Ikram, Aamer; Baig, Mirza Amir; Salman, Muhammad; Ghafoor, Tamkeen; Hussain, Zakir; Khan, Mumtaz Ali; Ansari, Jamil Ahmed; Syed, Asif; Javed, Wasif; Larik, Ehsan; Mohsan, Muhammad; Masood, Naveed; Iqbal, Zeeshan; Akram, Khurram. 2024. "Mortality Analysis of COVID-19 Confirmed Cases in Pakistan." Int J Front Sci 4, no. 2: 1.
Not implemented
SHARE